A study in patients with pancreatic cancer revealed that preoperative plasma levels of nine proteins, including complement factors C1q-B, C3 and C4A correlated with the 1-year disease-free survival (Lin et al, 2006). This evidence concerns the gene C3 and pancreatic neoplasm.